Skip to content
Inspirata Renews Digital Pathology Partnership with The Ohio State University
Ohio State University Digital Pathology

Inspirata’s very first Digital Pathology customer will extend its contract with the healthcare technology company to deliver reliable and innovative Digital Pathology solutions that support the university’s goals to be a pioneer in digital transformation.

Columbus, OH / Tampa, FL, March 23, 2021 / GlobeNewswire – Inspirata announced today a multi-year extension of its relationship with The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James). Initiated in 2016, the partnership between the two organizations has resulted in many important milestones in digital pathology, including scanning over 1.75 million whole slide images (WSIs) and enabling the first primary diagnosis sign-out through digital in the United States.

“This is a testament to the dedication of the team and our ability to deliver world-leading solutions reliably for several years in a row. We look forward to many more years of great successes with our partners at OSU,” says Dr. Mark Lloyd, Inspirata’s Founder and Executive Vice President.

“We have accomplished so much in collaboration with Inspirata. Our pathologists now have access to digital images of the clinical cases which allow us to review them and share them easily with colleagues for consultations and conferences. Remote reads through digital pathology have also allowed us to provide rapid, remote analysis throughout the recent COVID-19 pandemic, helping to ensure continuity of cancer care for patients at our hospital and our partner community hospitals,” says Wendy Frankel, MD, Distinguished Professor and Ralph W. and Helen Kurtz Chair in Pathology at Ohio State University College of Medicine.

About Inspirata

Inspirata, Inc. helps patients fighting cancer—and the clinicians they trust—to make every moment matter. Our comprehensive cancer informatics solutions bring disparate data together throughout the entire cancer care journey to drive informed decisions that improve survivorship.

Inspirata has assembled the most advanced and proven technologies to address the complex challenges of delivering cancer care and conducting ground-breaking research. We combine leading digital pathology solutions with automated cancer registry solutions, comprehensive cancer informatics and advanced patient engagement tools to bring users the broadest oncology informatics platform available globally. To learn more, visit

About the OSUCCC – James

The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard J. Solove Research Institute strives to create a cancer-free world by integrating scientific research with excellence in education and patient-centered care, a strategy that leads to better methods of prevention, detection and treatment. Ohio State is one of only 51 National Cancer Institute (NCI)-designated Comprehensive Cancer Centers and one of only a few centers funded by the NCI to conduct both phase I and phase II clinical trials on novel anticancer drugs sponsored by the NCI. As the cancer program’s 356-bed adult patient-care component, The James is one of the top cancer hospitals in the nation as ranked by U.S. News & World Report and has achieved Magnet designation, the highest honor an organization can receive for quality patient care and professional nursing practice. With 21 floors and more than 1.1 million square feet, The James is a transformational facility that fosters collaboration and integration of cancer research and clinical cancer care. To learn more, visit

Inspirata Media Contact:

Emil Mladenov
Vice President of Corporate and Digital Marketing
Tel: 813-467-7616

OSUCCC – James Media Contact:

Amanda Harper
Director, Media Relations, OSUCCC – James
Tel: 614-293-3737

Inspirata Joins Advarra’s New API Partner Program as an Inaugural Member

Inspirata Joins Advarra’s New API...

As new partners, Inspirata and Advarra will collaborate on ensuring integrations between Inspirata's Trial Navigator and Advarra's OnCore.
Inspirata Receives Industry’s First FDA Clearance for Scanner Agnostic Digital Pathology Software

Inspirata Receives Industry’s First FDA...

Inspirata is proud to announce that Dynamyx now holds the industry's first FDA clearance for digital pathology software with multiple…
NHS Cancer Alliance Implements Inspirata AI to Improve Clinical Trial Access for South West Patients

NHS Cancer Alliance Implements Inspirata...

NHS Cancer Alliance Implements Inspirata AI to Improve Access to Clinical Trials Across Somerset, Wiltshire, Avon and Gloucestershire.